AMARIN CORP PLC\UK Inventory, Finished Goods, Net of Reserves
AMARIN CORP PLC\UK (AMRN) had Inventory, Finished Goods, Net of Reserves of $12.37 million as of 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2018-02-27
- 2017-12-31: Inventory, Finished Goods, Net of Reserves $12.37M.
- 2017-09-30: Inventory, Finished Goods, Net of Reserves $13.52M.
- 2017-06-30: Inventory, Finished Goods, Net of Reserves $7.37M.
- 2017-03-31: Inventory, Finished Goods, Net of Reserves $8.67M.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2017-12-31 | $12.37M 10-K · filed 2018-02-27 |
| 2017-09-30 | $13.52M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $7.37M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $8.67M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $5.36M 10-K · filed 2018-02-27 |
| 2016-09-30 | $3.27M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $8.96M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $2.77M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $8.25M 10-K · filed 2017-03-01 |
| 2015-09-30 | $12.42M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $5.39M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $2.65M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $3.75M 10-K · filed 2016-02-25 |
| 2014-09-30 | $4.76M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $3.92M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $3.62M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $5.03M 10-K · filed 2015-03-03 |
| 2013-09-30 | $9.28M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $13.41M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $10.07M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $326.00K 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |